La cadena de opciones muestra datos clave de las opciones de acciones de Acuren a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Acuren..

Acuren (NYSE:TIC) Bolsa, Cadena de Opciones

Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.

Acciones que se mueven

ARHS

BASE

CAPR

CDNA

CTOR

DGLY

HLMN

ICCT

NTHI

TILE

Xos sorprende al mercado con sólidos resultados en 2024 y hace subir sus acciones antes de la apertura. Descubre más movimientos aquí.

Acciones de Xos (XOS) suben alrededor de un 9%; Aquí están 20 acciones que se mueven en el premercado de EE. UU.

Acuren Corp

TRITENT INTL CORP by Tritent International Corp.

Tritent Intl Corp

TICON PROPERTY FUND UNITS by Ticon Property Fund

Lack of communication and abrupt changes from President Donald Trump's administration have made it difficult to prepare for the rollout of the Make America Healthy Again food box initiative, according to George Matysik, executive director of Share Food Program.
&#8220;We have no details [about logistics of the MAHA food boxes], and this has been a continued challenge that we&#8217;ve had with this administration, where decisions are sort of made overnight,&#8221; said Matysik, in comments reported by <a href="https://www.cbsnews.com/news/trump-maha-food-box-replace-csfp-low-income-seniors/">CBS MoneyWatch</a> on May 7. He added that ongoing uncertainty is making it harder for food organizations to plan ahead.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
The <a href="https://www.whitehouse.gov/wp-content/uploads/2025/05/Fiscal-Year-2026-Discretionary-Budget-Request.pdf">2026 budget proposal</a> would eliminate the $425 million Commodity Supplemental Food Program, replacing it with "MAHA boxes" sourced directly from U.S. farmers, potentially impacting over <a href="https://www.ncsfpa.org/statement-in-response-to-the-presidents-fy26-discretionary-budget-request/">730,000 seniors'</a> grocery lifeline.
<h2 class="wp-block-heading">MAHA Boxes To Replace Shelf-Stable Support</h2>
"The boxes contain wholesome foods from domestic farms, and similar to the Farmers to Families Food Box, fresh foods," the U.S. Department of Agriculture said in an email to CBS MoneyWatch, adding that the MAHA initiative could "supplant or complement" existing programs.
According to the <a href="https://www.gao.gov/products/gao-21-353">U.S. Government Accountability Office</a>, the USDA awarded nearly $3 billion in contracts through the Farmers to Families Food Box Program. The program successfully delivered over 176 million food boxes to individuals and families in need across the country, relying on more than 200 contractors to distribute the boxes during the pandemic.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
<h2 class="wp-block-heading">Food Programs Already Feeling The Strain</h2>
The <a href="https://www.sharefoodprogram.org/">Share Food Program</a> has provided 32-pound food boxes to more than 300,000 children and over 4,000 seniors in Philadelphia, many of whom earn less than $23,000 a year.
According to CBS MoneyWatch, Matysik challenged the Trump administration's claim that current food bank offerings are nutritionally inadequate, explaining that their boxes contain lean proteins, pasta, and canned vegetables suitable for seniors—many of whom struggle with grocery access.
He expressed concern that MAHA's emphasis on fresh, perishable food might not meet the needs of seniors who depend on shelf-stable staples. Matysik also emphasized the logistical difficulties of getting fresh produce from farms to doorsteps without dedicated infrastructure.
See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>&nbsp;
<h2 class="wp-block-heading">Funding Cuts and Ripple Effects</h2>
The MAHA proposal arrives amid broader reductions in federal nutrition aid. In March, the Trump administration redirected $1 billion in school and food bank funding toward sourcing from local producers, <a href="https://www.politico.com/news/2025/03/10/usda-cancels-local-food-purchasing-for-schools-food-banks-00222796">according to Politico</a>.
The impact has already been felt. On April 13, <a href="https://www.ctinsider.com/connecticut/article/ct-food-insecurity-snap-meals-on-wheels-trump-20301048.php">CT Insider reported</a> that Connecticut Foodshare CEO Jason Jakubowski said that 34 federal food shipments were canceled without explanation, disrupting supplies to over 600 food banks statewide.
In April, USDA Secretary Brooke Rollins<a href="https://www.usda.gov/about-usda/news/press-releases/2025/04/15/rollins-applauds-arkansas-governor-submitting-snap-waiver-make-america-healthy-again"> expressed support </a>for Arkansas&#8217; proposal to restrict Supplemental Nutrition Assistance Program purchases of soda and candy, aligning with the MAHA initiative&#8217;s focus on improving nutrition.&nbsp;
Separately, Health and Human Services Secretary Robert F. Kennedy Jr. last month <a href="https://www.youtube.com/watch?v=SWwcIQ1dqnw">announced</a> plans to phase out synthetic food dyes from the U.S. food supply, as part of broader efforts to enhance dietary health.
Read Next:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'We Have No Details,' Says Food Program Director As Trump's 'MAHA Boxes' Threaten 730,000 Seniors' Grocery Lifeline

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) <a target="_blank" href="https://www.benzinga.com/topic/intel" rel="noreferrer noopener">explored selling its</a> network and edge businesses to focus on its core competencies, namely PC and data center chips.
Intel CEO Lip-Bu Tan voiced his plans to expand and build on its core competencies during Intel&#8217;s 40th-year celebration in Computex, Taipei, Reuters reported on Tuesday. He highlighted the firm&#8217;s share of ~68% of the PC chip market and 55% of that for data centers.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/05/45496055/intels-next-gen-ai-tech-steals-the-show-at-computex-2025" rel="noreferrer noopener">Intel&#8217;s Next-Gen AI Tech Steals The Show At Computex 2025</a>
Intel weighed the timing and mode of divestment of its NEX group, which makes chips for telecom equipment, Reuters reported, citing unnamed sources familiar with the matter.
Intel also explored selling its networking business due to the dominance of rivals like Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Reuters reported, citing unnamed sources familiar with the matter.
Intel stock has plunged over 33% in the last 12 months as it grappled with losses in its share in the data center and PC areas, which once served as its moat. It failed to tap the AI shift, akin to rivals like Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Intel <a target="_blank" href="https://www.benzinga.com/media/25/05/45456613/intel-cfo-says-new-chip-output-for-clients-will-be-minimal-eyes-foundry-breakeven-by-2027" rel="noreferrer noopener">fired its chief</a> Pat Gelsinger&nbsp;in 2024 after his turnaround plan to take on Taiwan Semiconductor failed to impress the board. Intel&nbsp;struggled as rivals&nbsp;Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) captured market share in data centers, AI, and GPUs.
Recently Intel CFO David Zinsner said&nbsp;Intel foundry is on track to break even in 2027 and would require external customers to generate low to mid-single digit billions in revenue to accomplish that.
In April, Intel&nbsp;sold a majority stake&nbsp;in its Altera unit to SilverLake for $4.46 billion.
Before the SilverLake sale, the company had been preparing to&nbsp;spin out&nbsp;Altera through a public offering under former CEO Pat Gelsinger, akin to Mobileye Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>), in 2022.
Price Actions:&nbsp;INTC stock is down 0.30% at $21.32 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45503727/nvidias-key-differentiators-include-its-ability-to-expand-its-addressable-market-analyst" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s Key Differentiators Include Its Ability To Expand Its Addressable Market: Analyst</a></li>
</ul>
Photo Courtesy Ascannio via Shutterstock

News

Asset Sales

Tech

Media

AVGO

INTC

MBLY

NVDA

Intel Eyes Exit From Networking And Edge Business To Refocus On PC, Data Center Dominance: Report

Strengthens Farm to Formula&#xAE; Positioning, Advancing Innovation &amp; Expansion into the ‘Better for You' Consumer Products
Right Product at the Right Time - Launch Aligns with Rapid Expansion in Global Sports Nutrition Market &nbsp;
BELVIDERE, NJ, May 20, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that it has officially launched the initial phase of its Kick. Sports Nutrition product line on Amazon. The launch is being executed in partnership with Pirawna, a leading e-commerce growth agency with over $500 million in Amazon revenue under management, to ensure a high-impact entry into the competitive sports nutrition market.

EDBL

Edible Garden Announces It Has Officially Launched The Initial Phase Of Its Kick. Sports Nutrition Product Line On Amazon

BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) has outperformed the market over the past 20 years by 5.27% on an annualized basis producing an average annual return of 13.58%. Currently, BlackRock has a market capitalization of $154.36 billion. 
Buying $100 In BLK: If an investor had bought $100 of BLK stock 20 years ago, it would be worth $1,275.85 today based on a price of $996.32 for BLK at the time of writing.
<h3>BlackRock's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747754114_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Earnings

MULN

Mullen Automotive Q2 EPS $(489.24), Sales $4.95M Up From $33.34K YoY

TD Securities analyst John Kernan maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Buy and raises the price target from $150 to $175.

Price Target

Analyst Ratings

DECK

TD Securities Maintains Buy on Deckers Outdoor, Raises Price Target to $175

WIIM

TNMG

TNL Mediagene shares are trading higher after Benchmark initiated coverage on the stock with a Speculative Buy rating and announced a $3.5 price target.

MEDIROM Healthcare Technologies shares are trading higher after the company reported a year-over-year increase in FY24 financial results.

Offerings

GENK

GEN Restaurant Group Files For Offering Of Up To 28.2M Shares Of Class A Common Stock By The Selling Stockholders

SatixFy Communications Ltd. Ordinary Share

SATX

SatixFy Communications shares are trading higher after the company announced it plans to increase the the merger agreement MDA Space to an all cash transaction of $3.00 per share.

TRON&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/trx/usd">TRX</a>) is currently trading at $0.2668, a <a href="https://www.benzinga.com/money/how-to-buy-tron-coin">1.65% increase in the last 24 hours</a>, and a surge of over 2% on the weekly chart, according to CoinMarketCap. The surge follows TRON&#8217;s expanding ecosystem and a significant shift in Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) activity from Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) to TRON.
The total USDT supply on the TRON network has surpassed Ethereum's, reaching $75.8 billion. TRON has beaten Ethereum in daily USDT transfer volume.
Since January 2025, TRON has peaked at $23.4 billion, in daily USDT transfers. This is more than 2x Ethereum's average of around $10 billion.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
This year, TRON's USDT supply has increased by 27%, or about $16 billion. TRON is positioned as the primary network for Tether-based transactions. TRON now holds over half of the total USDT supply globally, and Ethereum's share has dropped to approximately 49%, reported Cryptorank. Increased stablecoin liquidity on TRON could lead to more activity in TRX due to higher network demand.
According to The Crypto Times, SunPump, a platform for creating TRON-based meme coins, has announced a partnership with crypto exchange BingX.
The partnership will increase the popularity of TRON meme projects, and grow its meme community.&nbsp;
Wrapped TRX (CRYPTO: WTRX) recorded approximately 2.5 million transfers, indicating active DEX trading and DeFi activity. PayNet Coin (CRYPTO: PAYN) recorded about 1.3 million transfers, and Decentralized USD (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDD</a>) recorded 427,000. A diversifying mix of other tokens shows the network&#8217;s growing role in payments.
According to The Currency Analytics, large holders of TRON have started reducing their positions. A sell-off of 231 million TRX by whales has been noted by market observers. TRON experienced a 24% decline in its 24-hour trading volume, which now stands at $626.33 million, per CoinMarketCap data.&nbsp;
TRON's concentration by large holders is around 79%, and the market signal for TRON has moved to a mostly bearish zone, per IntoTheBlock.
According to TradingView, the RSI for TRX is around 64. There is room for upward price movement before overbought conditions are met.
TRX may retest the $0.28 resistance level. Investors and analysts are watching to see if TRX can move above $0.28 and target the $0.30 level.
Support for TRX is around the $0.23 level. TRON&#8217;s USDT dominance, its DeFi and meme coin ecosystem growth, and whale activity are factors that could influence its price.
At the current price, over 97% of TRON investors are profitable, which is a rare feat to achieve in the volatile crypto market.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$TRX

$USDD

$USDT

$WTRX

TRON Leads Stablecoin Race, Beats Ethereum Amid Growing Role In Meme Coin Sector

TD Securities analyst Bill Katz maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Buy and raises the price target from $95 to $113.

SCHW

TD Securities Maintains Buy on Charles Schwab, Raises Price Target to $113

Spain has ordered Airbnb to remove more than 65,000 listings that violated housing regulations, the Consumer Rights Ministry said Monday. 
The government claims the <a href="https://www.benzinga.com/25/05/45514426/spain-cracks-down-on-airbnb-asks-to-remove-over-65000-listings-amid-housing-crisis-no-more-excuses-enough-with-protecting-those">listings</a> lacked license numbers or failed to identify whether hosts were individuals or businesses. According to the AP, some listings included false or unverifiable information.
What To Know: The move is part of Spain's broader effort to combat its worsening housing affordability crisis. As the AP <a href="https://apnews.com/article/airbnb-spain-rental-listing-a91e605f6342db1b169d4f9d1681e9d4">reported</a>, protests have erupted nationwide in recent months over rising rents, which many blame on the surge in short-term rentals in tourist-heavy cities like Madrid and Barcelona.
Read Also: <a href="https://www.benzinga.com/news/25/05/45519469/tesla-stock-rises-after-musk-reaffirms-leadership-and-business-rebound">Tesla Stock Rises After Musk Reaffirms Leadership And Business Rebound</a>
Consumer Minister Pablo Bustinduy told reporters the government would no longer &#8220;protect those who make a business out of the right to housing." The AP noted that the initial removal order targets 5,800 listings, with two more waves planned to reach nearly 66,000.
Airbnb said it <a href="https://apnews.com/article/airbnb-spain-rental-listing-a91e605f6342db1b169d4f9d1681e9d4">plans to appeal</a>, arguing the ministry lacks authority over short-term rentals. A spokesperson told the AP that the company used "appropriate methodology" and that not all targeted listings require licenses.
This crackdown follows similar actions by cities such as Barcelona, which plans to phase out short-term rental licenses by 2028.
Price Action: ABNB shares are trading lower by some 2.61% to $133.03 during Tuesday trading.
<h2 class="wp-block-heading">How To Buy ABNB Stock</h2>
By now you're likely curious about how to participate in the market for Airbnb &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Airbnb, which is trading at $133.03 as of publishing time, $100 would buy you 0.75 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ABNB has a 52-week high of $163.93 and a 52-week low of $99.88.

ABNB

Spain Orders Airbnb (ABNB) To Remove 65,000 Listings: What's Going On?

Canaan Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) shares traded lower by 6.3% to 76 cents Tuesday morning after the crypto mining hardware maker reported first-quarter revenue of $82.8 million, topping its own guidance of $75 million but missing analysts' expectations of $90.1 million.
The company also <a href="https://www.benzinga.com/pressreleases/25/05/n45512808/canaan-inc-reports-unaudited-first-quarter-2025-financial-results">posted</a> a net loss of $86.4 million, narrowing from $92.9 million in the fourth-quarter but more than doubling year-over-year.
What To Know: Despite a 135.9% year-over-year revenue jump and a return to positive gross profit ($0.6 million vs. a $37.3 million loss last year), mounting operating and non-operating losses, including a $14.1 million loss on financial derivatives, dragged results.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45517785/bitcoin-to-hit-500000-by-2028-standard-chartered-says-as-etfs-buy-667m-on-monday">Bitcoin To Hit $500,000 By 2028, Standard Chartered Says, As ETFs Buy $667M On Monday</a>
Mining revenue reached a <a href="https://www.benzinga.com/pressreleases/25/05/n45512808/canaan-inc-reports-unaudited-first-quarter-2025-financial-results">record</a> $24.3 million, up 58.6% quarter-over-quarter, as Canaan mined 259 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) amid expanding U.S. and global capacity. 
The company noted challenges from new U.S. tariffs, increased mining costs and macro uncertainty, though it emphasized ongoing investment in R&amp;D and supply chain flexibility.
Looking ahead, Canaan guided second-quarter revenue of $100 million, falling short of the $139.96 million consensus estimate, further pressuring the stock.
Per-share net loss was 27 cents in the first-quarter, compared to 33 cents in the fourth-quarter and 16 cents a year ago. As of March 31, Canaan held 1,468.1 bitcoins and $96.8 million in cash.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45516604/senator-hagerty-says-stablecoin-issuers-may-surpass-foreign-governments-in-us-treasury-holdings">Senator Hagerty Says Stablecoin Issuers May Surpass Foreign Governments In US Treasury Holdings</a>
<h2 class="wp-block-heading">How To Buy CAN Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Canaan&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CAN has a 52-week high of $3.27 and a 52-week low of $0.53.

$BTC

Canaan Shares Dip On Q1 Revenue Miss And Weak Q2 Outlook

<a href="https://www.apple.com/newsroom/2025/05/apples-worldwide-developers-conference-kicks-off-june-9/" title="https://www.apple.com/newsroom/2025/05/apples-worldwide-developers-conference-kicks-off-june-9/">https://www.apple.com/newsroom/2025/05/apples-worldwide-developers-conference-kicks-off-june-9/</a>

Events

AAPL

'Apple's Worldwide Developers Conference Kicks Off June 9; The Annual Online Conference Takes Place June 9-13, Promising A Week Of Technology, Innovation, And Creativity'

Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) will release its quarterly earnings report on Wednesday, 2025-05-21. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Ucloudlink Group to report an earnings per share (EPS) of $-0.04.
The market awaits Ucloudlink Group's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
The company's EPS missed by $0.13 in the last quarter, leading to a 1.63% increase in the share price on the following day.
Here's a look at Ucloudlink Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>0.07</td>
<td>0.01</td>
<td>-0.01</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.08</td>
<td>0.10</td>
<td>0.07</td>
<td>0.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>3.0%</td>
<td>-3.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747753369_0.png" alt="eps graph" />
<h3>Performance of Ucloudlink Group Shares</h3>
Shares of Ucloudlink Group were trading at $1.319 as of May 19. Over the last 52-week period, shares are down 14.79%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/UCL/earnings">To track all earnings releases for Ucloudlink Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Ucloudlink Group

A notable insider purchase on May 19, was reported by J. Scott Kirby, Director at CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), based on the most recent SEC filing.
What Happened: Kirby made a significant move by purchasing 2,769 shares of CVS Health as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000064803/000112760225014955//Archives/edgar/data/64803/000112760225014955/0001127602-25-014955-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $167,441.
During Tuesday's morning session, CVS Health shares up by 1.1%, currently priced at $63.47.
<h3>About CVS Health</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
<h3>CVS Health: Financial Performance Dissected</h3>
Revenue Growth: CVS Health's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 6.96%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 15.22%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.41, CVS Health showcases strong earnings per share.
</li>
</ul>
Debt Management: CVS Health's debt-to-equity ratio stands notably higher than the industry average, reaching 1.06. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 14.98, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.21 is lower than the industry average, implying a discounted valuation for CVS Health's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): CVS Health's EV/EBITDA ratio at 9.98 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000064803">Check Out The Full List Of CVS Health's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Director At CVS Health Buys $167K of Stock

On May 19, Guy P Sansone, Board Member at CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: Sansone's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000064803/000112760225014959//Archives/edgar/data/64803/000112760225014959/0001127602-25-014959-index.htm">U.S. Securities and Exchange Commission</a> on Monday, involves purchasing 2,077 shares of CVS Health. The total transaction value is $125,596.
In the Tuesday's morning session, CVS Health's shares are currently trading at $63.47, experiencing a up of 1.1%.
<h3>Discovering CVS Health: A Closer Look</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
<h3>CVS Health's Economic Impact: An Analysis</h3>
Positive Revenue Trend: Examining CVS Health's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.96% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 15.22%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.41, CVS Health showcases strong earnings per share.
</li>
</ul>
Debt Management: CVS Health's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.06, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 14.98 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.21, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 9.98 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000064803">Check Out The Full List Of CVS Health's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

125K Reasons To Be Bullish On CVS Health Stock

It was revealed in a recent SEC filing that Douglas H Shulman, Board Member at CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) made a noteworthy insider purchase on May 19,.
What Happened: Shulman's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000064803/000112760225014960//Archives/edgar/data/64803/000112760225014960/0001127602-25-014960-index.htm">U.S. Securities and Exchange Commission</a> on Monday, involves purchasing 2,077 shares of CVS Health. The total transaction value is $125,596.
CVS Health's shares are actively trading at $63.47, experiencing a up of 1.1% during Tuesday's morning session.
<h3>All You Need to Know About CVS Health</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
<h3>CVS Health: Delving into Financials</h3>
Positive Revenue Trend: Examining CVS Health's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.96% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 15.22%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): CVS Health's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.41.
</li>
</ul>
Debt Management: CVS Health's debt-to-equity ratio surpasses industry norms, standing at 1.06. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 14.98 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.21 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 9.98, CVS Health could be considered undervalued.
</li>
</ul>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000064803">Check Out The Full List Of CVS Health's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member Of CVS Health Purchased $125K In Stock

Evogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-21. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Evogene to report an earnings per share (EPS) of $-0.73.
The announcement from Evogene is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.79, leading to a 4.94% increase in the share price on the subsequent day.
Here's a look at Evogene's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.73</td>
<td>-1.01</td>
<td>-1.20</td>
<td>-0.9</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.06</td>
<td>-1.31</td>
<td>-1.06</td>
<td>-0.8</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>1.0%</td>
<td>9.0%</td>
<td>14.000000000000002%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747753352_0.png" alt="eps graph" />
<h3>Evogene Share Price Analysis</h3>
Shares of Evogene were trading at $1.34 as of May 19. Over the last 52-week period, shares are down 81.1%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/EVGN/earnings">To track all earnings releases for Evogene visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVGN

Insights into Evogene's Upcoming Earnings

Press Releases

Acuren Corporation Confirms Date for Fourth Quarter and Full Year 2024 Earnings Release

Acuren Corporation Announces Results for the Fourth Quarter and Full Year 2024

Acuren Corporation Confirms Date for First Quarter 2025 Earnings Release

Acuren Corporation Announces Uplisting to the New York Stock Exchange

Acuren Corporation and NV5 Global, Inc. Announce Merger with $2 Billion Combined Revenue

Acuren Corporation Announces Results for the First Quarter 2025

TIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Acuren Corporation Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FL, TIC, NVEE on Behalf of Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FL, NVEE, TIC on Behalf of Shareholders

NV5 GLOBAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NV5 Global, Inc. - NVEE

Comments

Acuren

Acuren (TIC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL